Therefore, we aimed to determine whether the anti-inflammatory cytokine TGF-β2 would ameliorate obesity, glucose dyshomeostasis, and anxiety-like behaviors using a mouse model of T2D that was chronically infused with TGF-β2. Here, TGFB2 is linked to obesity due to melanocortin 4 receptor deficiency.